Carboxylesterases: Pharmacological Inhibition Regulated Expression and Transcriptional Involvement of Nuclear Receptors and other Transcription Factors-Reference-Cited by-同舟云学术

Carboxylesterases: Pharmacological Inhibition Regulated Expression and Transcriptional Involvement of Nuclear Receptors and other Transcription Factors

Published:2019 Issue: Volume:6 Page:
ISSN:2314-5714
Container-title:Nuclear Receptor Research
language:en
Short-container-title:

Author:

Shen Yuanjun¹,Shi Zhanquan²,Yan Bingfang²

Affiliation:

1. Pittsburgh Heart, Lung and Blood Vascular Medicine Institute, University of Pittsburgh Department of Medicine, Pittsburgh, PA 15261, USA

2. Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45229, USA

Publisher

KenzPub

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://www.kenzpub.com/journals/nurr/2019/101435.pdf

Reference152 articles.

2. Carboxylesterases;Yan,2014

3. Structural organization and characterization of the regulatory element of the human carboxylesterase (CES1A1 and CES1A2) genes;Hosokawa;Drug Metabolism and Pharmacokinetics,2008

4. Human carboxylesterases: An update on CES1, CES2 and CES3;Sanghani;Protein and Peptide Letters,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: an up-to-date review;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03

2. Metabolism Pathways of Major Therapeutics for Treating Monkeypox Mono- and Co-infection with Human Immunodeficient Virus or SARS-CoV-2;Current Drug Metabolism;2023-08-04

3. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

4. Viral target and metabolism‐based rationale for combined use of recently authorized small molecule COVID‐19 medicines: Molnupiravir, nirmatrelvir, and remdesivir;Fundamental & Clinical Pharmacology;2023-03-25

5. Major implications of single nucleotide polymorphisms in human carboxylesterase 1 on substrate bioavailability;Biotechnology and Genetic Engineering Reviews;2022-08-10